MGAM2 and Hyperglycemia: Pancreatic α-amylase and maltase glucoamylase inhibitors, often referred to as potent starch or carbohydrate blockers, are considered an effective intervention to mitigate hyperglycaemia by curbing the influx of glucose into the bloodstream by attenuating the hydrolysis and absorption of starch from food [12].